REBN vs RECT

REBN exhibits critical financial instability, characterized by a Piotroski F-Score of 4/9 and the absence of a calculable Altman Z-Score or Graham Number due to negative equity. The company is facing a severe liquidity crisis with a current ratio of 0.08, indicating an inability to meet short-term obligations. While gross margins are healthy at 55.51%, massive operating losses (-224.67% margin) and negative book value (P/B -4.66) suggest a high risk of insolvency. Recent short-term price gains appear speculative and are not supported by fundamental improvements.

RECT exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a conservative Debt/Equity ratio of 0.35. The stock is significantly undervalued, trading at $1.62 against a Graham Number of $2.57 and an intrinsic value of $5.90. Despite a devastating one-year price decline of 59.4%, explosive earnings growth (125% YoY) and a recent short-term price recovery suggest a potential value reversal. The company significantly outperforms sector averages in profitability and leverage, though it remains a high-risk micro-cap.